Hepatitis B virus infection and chronic liver disease in Taiwan
- PMID: 214987
Hepatitis B virus infection and chronic liver disease in Taiwan
Abstract
Three hundred and eighty-five patients mostly with chronic liver diseases and 729 apparently healthy adults were studied for hepatitis B surface antigen (HBsAg) with reversed passive hemagglutination and antibody (anti-HBs) with passive hemagglutination. In healthy adults around 15% was HBsAg positive and in 45% was anti-HBs positive, estimating hepatitis B virus (HBV) infection in nearly two thirds of the population. The infection already occurred before adulthood. The prevalences of HBsAg were invariably over 80% in chronic hepatitis, cirrhosis and hepatocellular carcinoma (hepatoma) indicating an intimate relationship to HBV. On the contrary, the positive rates of anti-HBs in these diseases were far lower than those in healthy people and patients with other diseases, this is similar to the situation in chronic HBsAg carriers. The prevalence of HBsAg in hepatoma patients was unusually high, being 82.7% in contrast to 11.9% in patients with other malignancies. Not only hepatoma patients with cirrhosis but also those without cirrhosis were found to have high prevalence of HBsAg. The fact indicates an even more intimate relationship between hepatoma and HBV.
Similar articles
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
-
Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands.Am J Gastroenterol. 1984 Aug;79(8):633-6. Am J Gastroenterol. 1984. PMID: 6087656
-
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. J Exp Clin Cancer Res. 1999. PMID: 10606185
-
Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?Eur J Med. 1992 Sep;1(5):288-94. Eur J Med. 1992. PMID: 1285245
-
Screening for hepatitis A and B antibodies in patients with chronic liver disease.Am J Med. 2005 Oct;118 Suppl 10A:28S-33S. doi: 10.1016/j.amjmed.2005.07.014. Am J Med. 2005. PMID: 16271538 Review.
Cited by
-
A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program.Cancer Causes Control. 1996 May;7(3):305-11. doi: 10.1007/BF00052935. Cancer Causes Control. 1996. PMID: 8734823
-
Phylodynamics of hepatitis B virus genotype B in East Asia: A population genomics analysis.J Biol Methods. 2025 Jan 17;12(1):e99010048. doi: 10.14440/jbm.2025.0084. eCollection 2025. J Biol Methods. 2025. PMID: 40200946 Free PMC article.
-
Viral hepatitis infections in southern Taiwan: a multicenter community-based study.Kaohsiung J Med Sci. 2010 Sep;26(9):461-9. doi: 10.1016/S1607-551X(10)70073-5. Kaohsiung J Med Sci. 2010. PMID: 20837342 Free PMC article.
-
Immunisation against hepatitis B in Taiwan.Gut. 1996;38 Suppl 2(Suppl 2):S67-8. doi: 10.1136/gut.38.suppl_2.s67. Gut. 1996. PMID: 8786059 Free PMC article. Review.
-
Hepatocellular carcinoma- etiologic considerations: a review of the literature.J Natl Med Assoc. 1981;73(7):601-7. J Natl Med Assoc. 1981. PMID: 6267318 Free PMC article. Review.